Empagliflozin in diabetes: A therapeutic light at the end of the cardiovascular tunnel?
Editor-in-Chief, Leeds, UK v.l.harper@leeds.ac.uk.
Peter J
PJ
Grant
D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D048909:Diabetes Complications / Q000188:drug therapy*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005960:Glucosides / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents; C570240:empagliflozin